taking tirzepatide and semaglutide together TrimRX Switching Between Semaglutide and Tirzepatide:

Enhances insulin secretion, protects metabolic health, and works synergistically with GLP-1 to minimize common gastrointestinal side effects

For Leave-In Conditioning & Light Styling

Proper Semaglutide dosing and administration can maximize the medication's efficacy, aiding in significant weight loss.

The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial programme demonstrated that adults using semaglutide 2.4 mg weekly alongside lifestyle intervention lost an average of approximately 15% of their body weight over 68 weeks, compared to around 2.4% with placebo. NICE approved Wegovy for use in specialist weight management services in the UK in 2023 (TA875), recognising its clinical effectiveness. Ongoing research continues to explore its cardiovascular benefits, with the SELECT trial showing a significant reduction in major cardiovascular events in people with obesity

Highlighting reduced polypharmacy and improved outcomes strengthens value propositions with providers and payers

From weight loss to hormone therapy, we offer expert care